Telomere length is associated with intima-media thickness in pediatric liver transplant patients: A prospective cohort study

Liver Transpl. 2022 Nov;28(11):1766-1775. doi: 10.1002/lt.26524. Epub 2022 Jun 22.

Abstract

Leukocyte telomere length (LTL) is a marker for biological age. Pediatric liver transplant recipients show a high rate of subclinical atherosclerosis, indicated by elevated intima-media thickness (IMT). We hypothesized that atherosclerosis is associated with biological age in these patients and investigated the course of LTL over time. We measured LTL from peripheral blood leukocytes by quantitative polymerase chain reaction and IMT from 97 pediatric patients after liver transplantation in a prospective cohort study. Of the patients, 71% (n = 69) had two or more assessments (total, 228 observations; median follow-up, 1.1 years). Lower LTL was associated with higher IMT (β = -0.701, p = 0.01) and higher aspartate aminotransferase (β = -0.001, p = 0.02), adjusted for age, sex, and age at transplantation. Of the patients, 45% showed decreasing LTL over time, whereas 55% exhibited stable LTL. Patients with stable LTL showed a decrease in IMT (median, -0.02 mm/year) and a decrease of tacrolimus trough levels (median, -0.08 μg/L/year). LTL is associated with IMT independent of age in pediatric liver transplant patients, suggesting that early aging contributes to the high burden of subclinical cardiovascular damage and may furthermore negatively affect the graft.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aspartate Aminotransferases
  • Atherosclerosis* / epidemiology
  • Atherosclerosis* / etiology
  • Carotid Intima-Media Thickness
  • Child
  • Humans
  • Leukocytes
  • Liver Transplantation* / adverse effects
  • Prospective Studies
  • Tacrolimus
  • Telomere

Substances

  • Aspartate Aminotransferases
  • Tacrolimus